Clinical Trial Update: A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effectiveness and safety of AMG 386 (trebananib) in combination with sorafenib for advanced or inoperable hepatocellular carcinoma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• AMG-386 (trebananib)
• Nexavar (Sorafenib)

Snippet

Sponsor: Amgen | Conditions: Advanced Hepatocellular Carcinoma, Inoperable Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED